| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $0 | — | — |
| SG&A Expense | $64K | — | +73.7% |
| Operating Income | -$64K | — | -73.7% |
| Interest Expense | $46K | — | +1382.9% |
| Net Income | -$114K | — | -231.0% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8K | -49.0% | -55.6% |
| Current Assets | $11K | -39.5% | -50.0% |
| Total Assets | $11K | -39.5% | -50.0% |
| Current Liabilities | $2.6M | +2.8% | +1.9% |
| Stockholders' Equity | -$2.6M | -3.1% | -2.3% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$47K | — | -21.3% |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $40K | — | +33.3% |